EP2991671
Skömmtun GLP-1 efnasambanda um munn
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
2.5.2014EP published:
15.8.2018EP application number:
14721834.1
EP translation filed:
18.9.2018Grant published:
15.10.2018EPO information:
European Patent Register
Max expiry date:
1.5.2034Expiry date:
1.5.2024
Title:
ORAL DOSING OF GLP-1 COMPOUNDS
Timeline
Today
2.5.2014EP application
15.8.2018EP Publication
18.9.2018Translation submitted
15.10.2018Registration published
1.5.2024Expires
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880, Bagsværd, DK
Inventor
Name:
NIELSEN, Flemming SeierAddress:
Bagsværd, DK
Name:
SAUERBERG, PerAddress:
Bagsværd, DK
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
13166205Date:
2.5.2013Country:
EP
Classification
Categories:
A61K 38/26, A61P 3/10
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 23.4.2019
Expires: 1.5.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 7
Paid: 21.4.2020
Expires: 1.5.2021
Payer: Patice ehf.
Number: 8
Paid: 21.4.2021
Expires: 1.5.2022
Payer: Patice ehf.
Number: 9
Paid: 19.4.2022
Expires: 1.5.2023
Payer: Patice ehf.
Number: 10
Paid: 22.4.2023
Expires: 1.5.2024
Payer: Árnason Faktor ehf.